Detection of Urinary Tract Pathology in Some Schistosoma Haematobium Infected Nigerian Adults
Overview
Affiliations
Screening for Schistosoma haematobium infection and its possible morbidity was carried out in 257 adult participants in Eggua community, Ogun State, Nigeria. Parasitological assessment for the presence of ova of S. haematobium in urine and abdominopelvic ultrasonographic examination for bladder and secondary kidney pathology were carried out. S. haematobium prevalence of 25.68% (66/257) was recorded among the participants. There was a significantly higher prevalence of 69.2% of urinary schistosomiasis in the females than the prevalence of 31.8% in males (P = 0.902). The intensity of infections was mostly light (55) (21.8%) compared to heavy (10) (3.9%) with the mean intensity of 16.7 eggs/10 mL urine. Structural bladder pathology prevalence among participants was 33.9%. The bladder and kidney pathologies observed by ultrasound in subjects with S. haematobium infections included abnormal bladder wall thickness (59%), abnormal bladder shape (15.2%), bladder wall irregularities (15.2%), bladder masses (1.5%), bladder calcification (1.5%), and hydronephrosis (3%). Infection with S. haematobium was associated with bladder pathology. Higher frequencies of bladder abnormalities were observed more in the participants with light intensity of S. haematobium infection than in those with heavy infection. More bladder pathology was also seen in women than in men, although this was not statistically significant. In conclusion, there is evidence that the development of bladder pathology may be associated with S. haematobium infection.
Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?.
Iya A, Beyer K, Kotecha P, Kibaru J, Abdullahi M, Alhassan S BMJ Open. 2022; 12(3):e049241.
PMID: 35260447 PMC: 8905928. DOI: 10.1136/bmjopen-2021-049241.
Shams M, Khazaei S, Ghasemi E, Nazari N, Javanmardi E, Majidiani H Trop Med Health. 2022; 50(1):12.
PMID: 35093180 PMC: 8800356. DOI: 10.1186/s41182-022-00402-x.
Onile O, Fadahunsi A, Adekunle A, Oyeyemi B, Anumudu C PeerJ. 2020; 8:e8795.
PMID: 33062404 PMC: 7534685. DOI: 10.7717/peerj.8795.
Pallangyo P, Bhalia S, Simelane N, Lyimo F, Swai H, Mkojera Z J Investig Med High Impact Case Rep. 2020; 8:2324709620910912.
PMID: 32131640 PMC: 7059228. DOI: 10.1177/2324709620910912.
Tetteh-Quarcoo P, Akuetteh B, Owusu I, Quayson S, Attah S, Armah R Can J Infect Dis Med Microbiol. 2019; 2019:7912186.
PMID: 31565106 PMC: 6745107. DOI: 10.1155/2019/7912186.